v3.24.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited)
9 Months Ended
Sep. 30, 2023
USD ($)
Cash flows used in operating activities:  
Net loss $ (6,636,695)
Stock based compensation 794,351
Amortization of intangibles 78,032
Unrealized gain and accrued interest on investments (369,467)
Changes in assets and liabilities:  
Increase in accounts payable and accrued expenses 1,052,872
Decrease in prepaid expenses & other assets 440,123
Net cash used in operating activities (4,640,784)
Cash flows used in investing activities:  
Purchase of investments (18,090,684)
Proceeds from maturity of investments 17,635,000
Net cash used in investing activities (455,684)
Cash flows provided by financing activities:  
Payment of amounts due to officers (450,000)
Proceeds from sale of equity securities, net 5,849,266
Net cash provided by financing activities 5,399,266
Net change in cash and cash equivalents: 302,798
Cash and cash equivalents - beginning of period 2,860,628
Cash and cash equivalents - end of period 3,163,426
Supplemental information - Non cash items:  
Offering expenses associated with warrant modification $ 238,231